BIOMAT Database Logo BIOMAT Database Logo

Human fibrinolysin in retinal occlusion. 1966

R T Batungbacal

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012171 Retinal Vessels The blood vessels which supply and drain the RETINA. Pecten Oculi,Retinal Vasculature,Retinal Blood Vessels,Retinal Blood Vessel,Retinal Vasculatures,Retinal Vessel,Vasculature, Retinal,Vessel, Retinal,Vessel, Retinal Blood
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease

Related Publications

R T Batungbacal
Experimental retinal vein occlusion and treatment with fibrinolysin.
August 1966, American journal of ophthalmology,
R T Batungbacal
Therapy of retinal vein occlusion. Use of fibrinolysin and anticoagulants.
March 1961, American journal of ophthalmology,
R T Batungbacal
An unusual case of central retinal vein occlusion, treated successfully with intravenous fibrinolysin.
October 1961, Canadian Medical Association journal,
R T Batungbacal
Thrombolysis with fibrinolysin in cerebral arterial occlusion.
August 1958, Journal of the American Medical Association,
R T Batungbacal
[FIBRINOLYSIN TREATMENT OF RETINAL ARTERY OBSTRUCTION].
September 1963, Rinsho ganka. Japanese journal of clinical ophthalmology,
R T Batungbacal
[Fibrinolysin (Merck) treatment of retinal vein thrombosis].
December 1961, Rinsho ganka. Japanese journal of clinical ophthalmology,
R T Batungbacal
Fibrinolytic treatment of retinal vein thrombosis. The use of Fibrinolysin Human Lyovac (Merck).
December 1961, Acta medica et biologica,
R T Batungbacal
ORAL ADMINISTRATION OF A FIBRINOLYSIN IN VASCULAR INFLAMMATION AND OCCLUSION.
February 1964, The Nebraska state medical journal,
R T Batungbacal
Thrombolysis in dogs with human fibrinolysin.
October 1959, The Journal of laboratory and clinical medicine,
R T Batungbacal
The fibrinolysin system in human skin.
January 1970, Biorheology,
Copied contents to your clipboard!